Galunisertib
Galunisertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against TGF-beta receptor type-1. In addition, it is known to target TGF-beta receptor type-2, activin receptor type-1B, and bone morphogenetic protein receptor type-1B.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
24 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | 4 | 2 | — | — | — | 4 | |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 2 | 3 | — | — | — | 4 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 3 | 1 | — | — | — | 3 |
| Colorectal neoplasms | D015179 | 2 | 2 | — | — | — | 2 | ||
| Glioma | D005910 | EFO_0000520 | 2 | 1 | — | — | — | 2 | |
| Neoplasm metastasis | D009362 | EFO_0009708 | 2 | 1 | — | — | — | 2 | |
| Renal cell carcinoma | D002292 | — | 1 | — | — | — | 1 | ||
| Nasopharyngeal neoplasms | D009303 | — | 1 | — | — | — | 1 | ||
| Non-small-cell lung carcinoma | D002289 | 1 | 1 | — | — | — | 1 | ||
| Prostatic neoplasms | D011471 | C61 | — | 1 | — | — | — | 1 |
Show 2 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | GALUNISERTIB |
| INN | galunisertib |
| Description | LY-2157299 is a pyrrolopyrazole that is 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole which is substituted at positions 2 and 3 by 6-methylpyridin-2-yl and 6-(aminocarbonyl)quinolin-4-yl groups, respectively. A Transforming growth factor-betaRI (TGF-betaRI) kinase inhibitor, it blocks TGF-beta-mediated tumor growth in glioblastoma. It has a role as a TGFbeta receptor antagonist and an antineoplastic agent. It is a member of quinolines, a pyrrolopyrazole, a member of methylpyridines, an aromatic amide and a monocarboxylic acid amide. |
| Classification | Small molecule |
| Drug class | serine/threonine kinase inhibitors |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1 |
Identifiers
| PDB | — |
| CAS-ID | 700874-72-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2364611 |
| ChEBI ID | — |
| PubChem CID | 10090485 |
| DrugBank | DB11911 |
| UNII ID | 3OKH1W5LZE (ChemIDplus, GSRS) |
Target
Agency Approved
TGFBR1
TGFBR1
Organism
Homo sapiens
Gene name
TGFBR1
Gene synonyms
ALK5, SKR4
NCBI Gene ID
Protein name
TGF-beta receptor type-1
Protein synonyms
activin A receptor type II-like kinase, 53kDa, Activin A receptor type II-like protein kinase of 53kD, Activin receptor-like kinase 5, ALK-5, ALK5, mutant transforming growth factor beta receptor I, Serine/threonine-protein kinase receptor R4, SKR4, TbetaR-I, TGF-beta receptor type I, TGF-beta type I receptor, transforming growth factor beta receptor I, Transforming growth factor-beta receptor type I
Uniprot ID
Mouse ortholog
Tgfbr1 (21812)
TGF-beta receptor type-1 (Q64729)
Alternate
TGFBR2
TGFBR2
ACVR1B
ACVR1B
BMPR1B
BMPR1B
Organism
Homo sapiens
Gene name
TGFBR2
Gene synonyms
NCBI Gene ID
Protein name
TGF-beta receptor type-2
Protein synonyms
TbetaR-II, TGF-beta receptor type II, TGF-beta receptor type IIB, TGF-beta type II receptor, transforming growth factor beta receptor II, transforming growth factor beta receptor type IIC, transforming growth factor, beta receptor II (70/80kDa), transforming growth factor, beta receptor II alpha, transforming growth factor, beta receptor II beta, transforming growth factor, beta receptor II delta, transforming growth factor, beta receptor II epsilon, transforming growth factor, beta receptor II gamma, Transforming growth factor-beta receptor type II
Uniprot ID
Mouse ortholog
Tgfbr2 (21813)
TGF-beta receptor type-2 (Q62312)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,421 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
11 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more